| Drug utilization studies H Gama Arquivos de medicina 22 (2/3), 69-74, 2008 | 94 | 2008 |
| Questionnaire design and the recall of pharmacological treatments: a systematic review H Gama, S Correia, N Lunet Pharmacoepidemiology and drug safety 18 (3), 175-187, 2009 | 73 | 2009 |
| Adjunctive eslicarbazepine acetate: a pooled analysis of three phase III trials V Biton, JB Rogin, G Krauss, B Abou-Khalil, JF Rocha, J Moreira, H Gama, ... Epilepsy & Behavior 72, 127-134, 2017 | 42 | 2017 |
| Effect of eslicarbazepine acetate on the pharmacokinetics of a combined ethinylestradiol/levonorgestrel oral contraceptive in healthy women A Falcão, M Vaz-da-Silva, H Gama, T Nunes, L Almeida, ... Epilepsy research 105 (3), 368-376, 2013 | 39 | 2013 |
| Effect of questionnaire structure on recall of drug utilization in a population of university students H Gama, S Correia, N Lunet BMC medical research methodology 9, 1-9, 2009 | 36 | 2009 |
| Safety profile of opicapone in the management of Parkinson’s disease A Lees, JJ Ferreira, JF Rocha, O Rascol, W Poewe, H Gama, ... Journal of Parkinson's disease 9 (4), 733-740, 2019 | 34 | 2019 |
| Effects of adjunctive eslicarbazepine acetate on neurocognitive functioning in children with refractory focal-onset seizures S Jóźwiak, P Veggiotti, J Moreira, H Gama, F Rocha, P Soares-da-Silva Epilepsy & Behavior 81, 1-11, 2018 | 34 | 2018 |
| Pooled efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: Data from four double‐blind placebo‐controlled pivotal phase … C Elger, M Koepp, E Trinka, V Villanueva, J Chaves, E Ben‐Menachen, ... CNS Neuroscience & Therapeutics 23 (12), 961-972, 2017 | 28 | 2017 |
| Safety profile of eslicarbazepine acetate as add-on therapy in adults with refractory focal-onset seizures: from clinical studies to 6 years of post-marketing experience H Gama, M Vieira, R Costa, J Graça, LM Magalhães, P Soares-da-Silva Drug Safety 40, 1231-1240, 2017 | 22 | 2017 |
| Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: a double-blind, randomized, placebo-controlled, parallel … F Kirkham, S Auvin, J Moreira, H Gama, AC Falcão, JF Rocha, ... Epilepsy & Behavior 105, 106962, 2020 | 18 | 2020 |
| Safety, tolerability, and pharmacokinetics of FAAH inhibitor BIA 10‐2474: a double‐blind, randomized, placebo‐controlled study in healthy volunteers JF Rocha, A Santos, H Gama, P Moser, A Falcão, P Pressman, ... Clinical Pharmacology & Therapeutics 111 (2), 391-403, 2022 | 16 | 2022 |
| Safety, tolerability and efficacy of eslicarbazepine acetate as adjunctive therapy in patients aged≥ 65 years with focal seizures R Costa, B Steinhoff, H Gama, F Ikedo, JF Rocha, P Soares-da-Silva Drugs & Aging 35, 1109-1117, 2018 | 16 | 2018 |
| Eslicarbazepine acetate exposure in pregnant women with epilepsy R Costa, LM Magalhães, J Graça, M Vieira, H Gama, J Moreira, JF Rocha, ... Seizure 58, 72-74, 2018 | 15 | 2018 |
| Factors associated with chloroquine induced pruritus during malaria treatment in Mozambican University students H Gama, A Ismael, F Sitoi, A Matola, H Barros, N Lunet Gaceta Sanitaria 23, 306-310, 2009 | 14 | 2009 |
| Psychiatric and cognitive adverse events: a pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures E Andermann, V Biton, SR Benbadis, B Shneker, AK Shah, M Carreño, ... Epilepsy & Behavior 82, 119-127, 2018 | 13 | 2018 |
| Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials G Krauss, V Biton, JH Harvey, C Elger, E Trinka, PS da Silva, H Gama, ... Epilepsy Research 139, 1-8, 2018 | 12 | 2018 |
| Tolerability, pharmacokinetic and pharmacodynamic profile of BIA 10-2474 in healthy volunteers following multiple ascending doses F Rocha, A Santos, D Chassard, A Patat, A Astruc, A Falcão Proc. Br. Pharmacol. Soc. at http://www. pa2online. org/article/article. jsp, 2016 | 12 | 2016 |
| Hepatic safety of opicapone in Parkinson's disease patients N Lopes, J Ferreira, A Lees, H Gama, A Santos, C Oliveira, R Costa, ... Movement Disorders 30, S101-S101, 2015 | 12 | 2015 |
| Safety and efficacy of eslicarbazepine acetate treatment in elderly patients R Costa, C Oliveira, N Lopes, H Gama, R Sousa, T Nunes, ... Epilepsia 55, 112-112, 2014 | 12 | 2014 |
| The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I … JF Rocha, G Ebersbach, A Lees, E Tolosa, JJ Ferreira, W Poewe, ... Frontiers in Neurology 12, 754016, 2021 | 11 | 2021 |
Joaquim FerreiraFaculdade de Medicina, Universidade de LisboaVerifierad e-postadress på medicina.ulisboa.pt
